DRG 250

Surgical DRG

Percutaneous Cardiovascular Procedures without Intraluminal Device with MCC

TypeSurgicalMDC05

What is MS-DRG 250?

MS-DRG 250 is a Surgical Medicare Severity Diagnosis Related Group under Major Diagnostic Category 05 (MDC 05) with a Major Complication or Comorbidity (MCC). For FY 2026 it carries a relative weight of 2.1825 with a geometric mean length of stay of 3.1 days and an arithmetic mean of 4.3 days. Hospitals use this grouping to determine reimbursement for inpatient stays under Medicare.

Classification
Surgical DRG
Procedure-driven grouping
Linked Codes
0 diagnosis
35 procedure

FY 2026 Payment Data

Official values from Table 5 of the FY 2026 IPPS Final Rule (CMS).

Relative Weight
2.1825
Payment multiplier vs. average case (1.0)
Geometric Mean LOS
3.1 days
Used for transfer payment calculations
Arithmetic Mean LOS
4.3 days
Average length of stay
Post-Acute Transfer
No
Not subject to the transfer policy

Related MS-DRGs in This Severity Group

The same clinical condition is split into separate DRGs by complication severity. MCC pays more than CC, which pays more than no CC/MCC.

DRGTitleRel. WeightGMLOS
250Percutaneous Cardiovascular Procedures without Intraluminal Device with MCCThis page2.18253.1 days
251Percutaneous Cardiovascular Procedures without Intraluminal Device without MCC1.49452 days

Linked ICD-10-PCS Procedure Mappings

  • 02570ZK

    Destruction of Left Atrial Appendage, Open Approach

    BillableSection 0
  • 02700ZZ

    Dilation of Coronary Artery, One Artery, Open Approach

    BillableSection 0
  • 02710ZZ

    Dilation of Coronary Artery, Two Arteries, Open Approach

    BillableSection 0
  • 02720ZZ

    Dilation of Coronary Artery, Three Arteries, Open Approach

    BillableSection 0
  • 02730ZZ

    Dilation of Coronary Artery, Four or More Arteries, Open Approach

    BillableSection 0
  • 02B70ZK

    Excision of Left Atrial Appendage, Open Approach

    BillableSection 0
  • 02FP3Z0

    Fragmentation of Pulmonary Trunk, Percutaneous Approach, Ultrasonic

    BillableSection 0
  • 02FP3ZZ

    Fragmentation of Pulmonary Trunk, Percutaneous Approach

    BillableSection 0
  • 02FQ3Z0

    Fragmentation of Right Pulmonary Artery, Percutaneous Approach, Ultrasonic

    BillableSection 0
  • 02FQ3ZZ

    Fragmentation of Right Pulmonary Artery, Percutaneous Approach

    BillableSection 0
  • 02FR3Z0

    Fragmentation of Left Pulmonary Artery, Percutaneous Approach, Ultrasonic

    BillableSection 0
  • 02FR3ZZ

    Fragmentation of Left Pulmonary Artery, Percutaneous Approach

    BillableSection 0
  • 02FS3Z0

    Fragmentation of Right Pulmonary Vein, Percutaneous Approach, Ultrasonic

    BillableSection 0
  • 02FS3ZZ

    Fragmentation of Right Pulmonary Vein, Percutaneous Approach

    BillableSection 0
  • 02FT3Z0

    Fragmentation of Left Pulmonary Vein, Percutaneous Approach, Ultrasonic

    BillableSection 0
  • 02FT3ZZ

    Fragmentation of Left Pulmonary Vein, Percutaneous Approach

    BillableSection 0
  • 02U037Z

    Supplement Coronary Artery, One Artery with Autologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02U038Z

    Supplement Coronary Artery, One Artery with Zooplastic Tissue, Percutaneous Approach

    BillableSection 0
  • 02U03JZ

    Supplement Coronary Artery, One Artery with Synthetic Substitute, Percutaneous Approach

    BillableSection 0
  • 02U03KZ

    Supplement Coronary Artery, One Artery with Nonautologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02U137Z

    Supplement Coronary Artery, Two Arteries with Autologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02U138Z

    Supplement Coronary Artery, Two Arteries with Zooplastic Tissue, Percutaneous Approach

    BillableSection 0
  • 02U13JZ

    Supplement Coronary Artery, Two Arteries with Synthetic Substitute, Percutaneous Approach

    BillableSection 0
  • 02U13KZ

    Supplement Coronary Artery, Two Arteries with Nonautologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02U237Z

    Supplement Coronary Artery, Three Arteries with Autologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02U238Z

    Supplement Coronary Artery, Three Arteries with Zooplastic Tissue, Percutaneous Approach

    BillableSection 0
  • 02U23JZ

    Supplement Coronary Artery, Three Arteries with Synthetic Substitute, Percutaneous Approach

    BillableSection 0
  • 02U23KZ

    Supplement Coronary Artery, Three Arteries with Nonautologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02U337Z

    Supplement Coronary Artery, Four or More Arteries with Autologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02U338Z

    Supplement Coronary Artery, Four or More Arteries with Zooplastic Tissue, Percutaneous Approach

    BillableSection 0
  • 02U33JZ

    Supplement Coronary Artery, Four or More Arteries with Synthetic Substitute, Percutaneous Approach

    BillableSection 0
  • 02U33KZ

    Supplement Coronary Artery, Four or More Arteries with Nonautologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02U73JZ

    Supplement Left Atrium with Synthetic Substitute, Percutaneous Approach

    BillableSection 0
  • 02U74JZ

    Supplement Left Atrium with Synthetic Substitute, Percutaneous Endoscopic Approach

    BillableSection 0
  • X2A7358

    Intermittent Coronary Sinus Occlusion, Percutaneous Approach, New Technology Group 8

    BillableSection X